Kistler-Tiffany Companies’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
Other funds holding TDOC
AIM
NAMA
SOMRS
Kistler-Tiffany Companies's TDOC Position: Q1 2023 in Review
Kistler-Tiffany Companies sold out of Teladoc Health (TDOC) in Q1 2023, closing a stake of 157 shares — an estimated $3.71K sold.
Kistler-Tiffany Companies first reported a position in TDOC in Q3 2019 and held it in 14 quarters. The position peaked at $56K in Q4 2020. 430 funds tracked by Wall St. Rank hold TDOC as of Q1 2023.
- Kistler-Tiffany Companies reported no remaining Teladoc Health position as of Q1 2023 after selling out during the quarter.
- Kistler-Tiffany Companies sold 157 Teladoc Health shares in Q1 2023, an estimated $3.71K.
- Kistler-Tiffany Companies first reported a position in Teladoc Health in Q3 2019 and held it in 14 quarters.
- Kistler-Tiffany Companies's Teladoc Health position peaked at $56K in Q4 2020.
- 430 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2023.
Based on Kistler-Tiffany Companies's 13F filing for Q1 2023, filed 3 May 2023.